Cipher Pharmaceuticals Schedules Q3 2026 Earnings Call
Cipher Pharmaceuticals scheduled its Q3 2026 earnings release and conference call.
Related stories
I-80 Gold Posts Q3 Adjusted Loss of $0.06 Per Share
M impact | EQUITY | Nov 02, 2026, 11:04 PM UTC
I-80 Gold reports Q3 production of 11,685 ounces
M impact | EQUITY | Nov 02, 2026, 11:04 PM UTC
Backblaze Raises Full-Year Revenue Outlook; Shares Surge 33% After Hours
Backblaze raised its full-year revenue outlook. Shares rose 33% to $9.84 in after-hours trading Monday, after closing down 2.5% at $7.40; the stock is up 59% year to date.
M impact | EQUITY | Nov 02, 2026, 11:04 PM UTC
AH Realty Trust Q3 Earnings Snapshot
AH Realty Trust reported on Monday; the available text provides no earnings figures.
M impact | EQUITY | Nov 02, 2026, 11:03 PM UTC
Hinge Health Reports Q3 Revenue of $235 Million, Raises 2026 Guidance
Hinge Health reported adjusted EPS of $0.71 versus FactSet consensus of $0.58. It raised its 2026 revenue outlook to $879 million-$881 million from a prior FactSet estimate of $860
M impact | EQUITY | Nov 02, 2026, 11:03 PM UTC
Topaz Energy Reports Q3 2026 Results, Raises Royalty Production 9%
Average royalty production rose 9% year over year to 23,507 boe/d. Topaz reported cash flow of $0.56 per share and net income of $0.21 per share, reaffirmed 2026 production and deb
M impact | EQUITY | Nov 02, 2026, 11:03 PM UTC